Diplomat acquires Focus Rx

FLINT, Mich. — Diplomat Pharmacy has a new addition to its ranks. The company on Monday announced the closing of its acquisition of Focus Rx Pharmacy Services, a New York-based specialty and infusion pharmacy with two locations in the state.

Focus Rx offers home infusion and specialty prescription management services, and its acquisition will strengthen Diplomat’s ability to deliver solutions for increasing infusion therapy demand, the company said.

“This partnership opens growth opportunities, especially in the key markets of New York and New Jersey,” Diplomat VP and president of Diplomat Specialty Infusion Group Phil Rielly said. “Focus Rx brings over 15 regional and national payor contracts, boosting Diplomat’s prescription and payer access.”

Diplomat said Focus Rx’s nutrition deficiency business would complement its existing Thrive Rx nutrition division of Diplomat Specialty Infusion Group, offering growth in the New York market. The company expects Focus Rx to generate roughly $47 million in revenue and $3 million in earnings before interest, taxes, depreciation and amortization for the full year 2017.

“As a specialty infusion provider in today’s rapidly evolving health care environment, we are excited to partner with Diplomat to enhance the delivery of comprehensive and personalized services to our patients,” Focus Rx CEO Lou Puleo said. “Our efforts improve patient results, as well as the clinical, operational, and financial well-being of our partners. Diplomat will further our commitment, enabling us to deliver integrated health care services to new and existing consumers and advancing our strong clinical expertise.”